መነሻ › አሠሪዎች › SystImmune, Inc.
SystImmune, Inc.: H-1B ደመወዞች እና ስፖንሰርሺፕ
SystImmune, Inc. በፋይናንስ ዓመታት 2023–2026 ለH-1B እና ለተዛማጅ ቪዛዎች 20 የሥራ ሁኔታ ማመልከቻዎችን አቅርቧል፤ የተረጋገጡ፡ 15። መካከለኛ የተገለጸ ደመወዝ፡ $114,026።
SystImmune, Inc. H-1B ቪዛዎችን ይደግፋል?
SystImmune, Inc. በፋይናንስ ዓመታት 2023–2026 20 የሥራ ሁኔታ ማመልከቻዎችን አቅርቧል፤ የቅርብ ጊዜ የቀረበው በ27 ኤፕሪ 2026። LCA የH-1B ጥያቄ የመጀመሪያ ደረጃ ስለሆነ፣ አሠሳሪው H-1B ሠራተኞችን ደግፏል ወይም ለመደገፍ ተዘጋጅቷል፤ ለማንኛውም የተወሰነ ሥራ ስፖንሰርሺፕ አያረጋግጥም። የአሠሳሪውን የራሱ የሥራ ዝርዝሮች ይመልከቱ።
በሥራ ማዕረግ የተከፋፈሉ ደመወዞች
| የስራ አስፈጻሚ | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| Scientist, Immuno-Oncology | 3 | $100,000 |
| Biostatistician | 2 | $117,013 |
| Clinical Data Manager | 2 | $145,494 |
| Accountant | 2 | $85,862 |
| Accounting Manager | 2 | $120,000 |
| Project & Operations Assistant | 2 | $82,000 |
| VP, Finance & Operations | 1 | $210,000 |
| Scientist, Cell Science | 1 | $90,000 |
| Chief Technology and Data Officer | 1 | $550,000 |
| Staff Accountant | 1 | $75,000 |
| Manager of Cell Therapy Development and Operations (CTDO) | 1 | — |
| Manager of Chief Technology and Data Officer (CTDO) Office | 1 | $130,000 |
| Financial Analyst | 1 | $80,746 |
በፋይናንስ ዓመት መሠረት ማመልከቻዎች
| የፋይናንስ ዓመት | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| FY2023 | 1 | $210,000 |
| FY2025 | 14 | $110,000 |
| FY2026 | 5 | $97,386 |
የሚገባ ደመወዝ ደረጃዎች
የሥራ ሚኒስቴር ለእያንዳንዱ ሙያ እና አካባቢ ከደረጃ I (መግቢያ) እስከ ደረጃ IV (ሙሉ በሙሉ ብቁ) ድረስ አራት የሚገባ ደመወዝ ደረጃዎችን ይወስናል። አሠሳሪው ከሥራው መስፈርቶች ጋር የሚስማማውን ደረጃ ይመርጣል።
ሥራዎቹ የት እንዳሉ
ሙያዎች
- Accountants and Auditors5
- Statisticians3
- Molecular and Cellular Biologists3
- Medical Scientists, Except Epidemiologists3
- Data Scientists2
- Project Management Specialists2
- General and Operations Managers1
- Financial and Investment Analysts1
የቅርብ ጊዜ ማመልከቻዎች
| የስራ አስፈጻሚ | መሠረታዊ ደመወዝ | አድራሻ | የቀረበበት | የመጀመሪያ ቀን | ሁኔታ |
|---|---|---|---|---|---|
| Biostatistician | $114,026–$134,026 ደረጃ III | Redmond, WA | 27 ኤፕሪ 2026 | 1 ኦክቶ 2026 | የተረጋገጠ |
| Financial Analyst | $80,746–$100,000 ደረጃ I | Redmond, WA | 27 ኤፕሪ 2026 | 1 ኦክቶ 2026 | የተረጋገጠ |
| Manager of Chief Technology and Data Officer (CTDO) Office | $130,000 ደረጃ III | Redmond, WA | 31 ዲሴም 2025 | 16 ጃንዩ 2026 | የተረጋገጠ |
| Manager of Cell Therapy Development and Operations (CTDO) | $130,000 ደረጃ III | Redmond, WA | 30 ዲሴም 2025 | 16 ጃንዩ 2026 | የተወገደ |
| Staff Accountant | $75,000–$95,000 ደረጃ I | Redmond, WA | 26 ኖቬም 2025 | 15 ዲሴም 2025 | የተረጋገጠ |
| Clinical Data Manager | $140,000–$150,000 ደረጃ II | Redmond, WA | 20 ጁን 2025 | 14 ጁላይ 2025 | የተረጋገጠ |
| Scientist, Immuno-Oncology | $100,000–$120,000 ደረጃ II | Redmond, WA | 21 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ |
| Project & Operations Assistant | $82,000–$92,000 ደረጃ I | Redmond, WA | 20 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ |
| Scientist, Immuno-Oncology | $100,000–$120,000 ደረጃ II | Redmond, WA | 20 ሜይ 2025 | 1 ኦክቶ 2025 | የተወገደ |
| Accountant | $85,862–$95,862 ደረጃ II | Redmond, WA | 20 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ |
| Accounting Manager | $120,000–$130,000 ደረጃ III | Redmond, WA | 20 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ |
| Accountant | $85,862–$95,862 ደረጃ II | Redmond, WA | 16 ሜይ 2025 | 1 ኦክቶ 2025 | የተወገደ |
| Accounting Manager | $120,000–$130,000 ደረጃ III | Redmond, WA | 16 ሜይ 2025 | 1 ኦክቶ 2025 | የተወገደ |
| Scientist, Immuno-Oncology | $100,000–$120,000 ደረጃ II | Redmond, WA | 16 ሜይ 2025 | 1 ኦክቶ 2025 | የተወገደ |
| Project & Operations Assistant | $82,000–$92,000 ደረጃ I | Redmond, WA | 9 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ፣ ከዚያም የተወገደ |
| Chief Technology and Data Officer | $550,000–$580,000 ደረጃ IV | Redmond, WA | 28 ፌብሩ 2025 | 30 ኦገስ 2025 | የተረጋገጠ |
| Clinical Data Manager | $150,987–$180,987 ደረጃ III | Redmond, WA | 19 ፌብሩ 2025 | 3 ማርች 2025 | የተረጋገጠ |
| Biostatistician | $120,000 ደረጃ II | Redmond, WA | 5 ማርች 2024 | 18 ማርች 2024 | የተረጋገጠ፣ ከዚያም የተወገደ |
| VP, Finance & Operations | $210,000 ደረጃ I | Redmond, WA | 24 ጁላይ 2023 | 2 ሴፕቴ 2023 | የተረጋገጠ |
| Scientist, Cell Science | $90,000 ደረጃ II | Redmond, WA | 11 ሜይ 2022 | 1 ኦክቶ 2022 | የተረጋገጠ፣ ከዚያም የተወገደ |
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።